Encysive Pharmaceuticals Says FDA Finds Response To Thelin Incomplete

December 14, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Dec 14 (Reuters) - Encysive Pharmaceuticals Inc. (ENCY.O: Quote, Profile , Research) said the U.S. Food and Drug Administration has found its response to a July "approvable letter", for its experimental treatment Thelin incomplete.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

Food and Drug Administration (FDA)